This study is currently not recruiting participants.

Cardiac Surgery in Abdominal Organ Transplant Patients

Study on Postoperative Outcomes in Abdominal Organ Disease

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The aim of this study is to investigate the postoperative outcomes, including overall mortality and major cardiovascular adverse events, in patients with end stage abdominal organ disease or prior abdominal organ transplantation.

Detailed description of study

The aim of this study is to investigate the postoperative outcomes, including overall mortality and major cardiovascular adverse events, in patients with end stage abdominal organ disease or prior abdominal organ transplantation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: organ transplant
  • Age: 100 years or below
  • Gender: All

This study investigates the outcomes after surgery in patients who have end stage abdominal organ disease or have had an abdominal organ transplant. The main focus is on understanding how these patients recover and the risks they face, such as mortality and major heart-related events after the surgery.

Participants in this study will undergo various procedures to monitor their recovery. These procedures are designed to track their health and identify any major cardiovascular events that might occur after surgery. The study aims to gather data to better understand these postoperative outcomes.

  • Who can participate: The study is looking for patients aged 18 and older who have end stage abdominal organ disease or have previously received an abdominal organ transplant.
  • Study details: Participants will be monitored for their recovery and any major cardiovascular events after surgery. The study involves tracking health outcomes to understand postoperative risks.
Updated on 19 Feb 2024. Study ID: 1802083048

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team